objectivesmani
patient
influenza
one
viral
agent
coinfect
frequenc
report
high
impact
respiratori
viru
copathogen
influenza
diseas
unclear
sought
determin
respiratori
viru
coinfect
pandem
alter
clinic
diseas
methodsrespiratori
sampl
patient
identifi
without
influenza
respect
screen
presenc
season
respiratori
virus
multiplex
rtpcr
diseas
sever
coinfect
monoinfect
patient
quantifi
use
standard
clinic
sever
scale
influenza
viral
load
calcul
quantit
rtpcr
resultsthirti
influenza
sampl
screen
posit
presenc
viral
copathogen
promin
copathogen
includ
rhinoviru
coronavirus
median
clinic
sever
monoinfect
coinfect
group
patient
coinfect
rhinoviru
tend
lower
clinic
sever
median
wherea
non
rhinoviru
coinfect
substanti
higher
clinic
sever
median
differ
viral
load
observ
coinfect
mono
infect
group
conclusionsrespiratori
virus
coinfect
patient
influenza
diseas
patient
coinfect
rhinoviru
less
sever
diseas
nonrhinoviru
coinfect
associ
substanti
higher
sever
without
chang
influenza
viral
titer
respiratori
tract
diseas
major
caus
morbid
mortal
throughout
world
account
approxim
million
death
worldwid
virus
influenza
parainfluenza
respiratori
syncyti
viru
rsv
adenoviru
well
describ
major
respiratori
pathogen
advanc
molecular
genom
techniqu
increas
detect
identif
new
respiratori
virus
also
renew
attent
respiratori
virus
includ
human
rhinoviru
coronavirus
mount
evid
virus
also
lead
clinic
sever
diseas
current
major
practition
approach
respiratori
viral
infect
assum
singleag
etiolog
howev
group
other
realiz
substanti
number
patient
respiratori
tract
diseas
one
viral
pathogen
frequenc
respiratori
viru
coinfect
vari
wide
literatur
often
report
one
report
high
understand
mani
respiratori
virus
circul
similar
time
often
wintertim
predomin
temper
climat
recent
brunstein
et
al
provid
statist
evid
coinfect
certain
pathogen
occur
frequent
expect
coinfect
random
influenza
often
identifi
coinfect
virus
sever
group
specul
earli
spread
influenza
may
alter
cocircul
tradit
season
virus
increas
evid
literatur
import
polymicrobi
infect
virusviru
interact
recogn
directli
indirectli
immunolog
interact
yet
clinic
relev
respiratori
viru
copathogen
associ
diseas
unclear
sever
studi
report
viral
coinfect
associ
increas
morbid
studi
show
greater
hospit
rate
admiss
intens
care
associ
coinfect
howev
remain
controversi
sever
report
describ
coinfect
increas
patient
morbid
one
explan
disagr
assumpt
diseas
sever
associ
dual
infect
independ
copathogen
involv
aberl
et
al
found
dual
infect
rhinoviru
rsv
associ
reduc
respons
sever
clinic
cours
coinfect
combin
anim
model
specif
dual
respiratori
infect
result
either
enhanc
clinic
manifest
viral
interfer
find
suggest
certain
copathogen
pair
may
clinic
relev
other
remain
gap
knowledg
understand
respiratori
viru
coinfect
previou
investig
influenza
coinfect
either
combin
viral
copathogen
togeth
analysi
address
clinic
outcom
studi
quantifi
effect
viral
coinfect
lack
yet
line
investig
paramount
understand
viral
pathogenesi
studi
identifi
promin
viral
copathogen
occur
pandem
influenza
compar
result
clinic
diseas
first
studi
critic
look
specif
copathogen
alter
result
influenza
diseas
effect
influenza
viral
load
septemb
novemb
correspond
time
major
pandem
wave
archiv
respiratori
specimen
screen
posit
influenza
comparison
select
influenza
neg
sampl
collect
period
sampl
origin
emerg
depart
inpati
ward
intens
care
unit
hospit
affili
primari
care
outpati
clinic
sampl
submit
core
laboratori
discret
primari
medic
team
influenza
test
influenza
screen
perform
either
direct
immunofluoresc
assay
dfa
real
time
rtpcr
use
standard
techniqu
sampl
confirm
rtpcr
use
primer
set
target
pandem
nucleic
acid
respiratori
sampl
extract
use
either
qiacub
qiaamp
viral
rna
kit
qiagen
valencia
ca
total
na
isol
kit
appli
biosystem
foster
citi
ca
accord
manufactur
protocol
random
hexam
primer
invitrogen
carlsbad
ca
use
creat
cdna
librari
specimen
revers
transcript
reaction
perform
mmlv
rt
invitrogen
carlsbad
ca
accord
manufactur
specif
cdna
subsequ
screen
presenc
common
respiratori
virus
includ
human
parainfluenza
hpiv
human
metapneumoviru
mpv
respiratori
syncyti
viru
rsv
rhinoviru
rv
adenoviru
adv
human
coronavirus
hcov
primer
probe
set
use
multiplex
realtim
rtpcr
detect
describ
screen
respiratori
sampl
condit
describ
except
chlamydia
mycoplasma
enteroviru
primer
set
omit
addit
recent
recogn
respiratori
virus
includ
coronaviru
wu
polyomaviru
human
bocaviru
screen
use
convent
rtpcr
separ
reaction
use
primer
reaction
condit
describ
medic
record
positiveindividu
review
record
standard
collect
form
clinic
sever
score
criteria
describ
martinello
et
al
clinic
sever
score
css
chosen
design
specif
around
respiratori
diseas
css
rang
two
point
assign
patient
requir
mechan
ventil
support
ill
point
assign
follow
hospit
admiss
prolong
hospit
day
sever
hypoxia
use
supplement
oxygen
mono
coinfect
individu
compar
clinic
sever
defin
sever
respiratori
diseas
patient
css
sampl
collect
chart
analysi
approv
univers
hospitalcas
medic
center
irb
quantit
analysi
perform
stepon
plu
taqman
real
time
pcr
appli
biosystem
branchburg
nj
use
taqman
univers
pcr
master
mix
appli
biosystem
branchburg
nj
cdna
sampl
primersprob
target
matrix
gene
refer
standard
prepar
use
cdna
fragment
matrix
gene
human
rnase
p
amplifi
convent
rtpcr
gel
purifi
qiaquick
qiagen
valencia
ca
quantifi
use
spectrophotomet
beckman
coulter
brea
ca
statist
analysi
perform
use
r
softwar
version
student
ttest
use
analyz
mean
viral
copi
number
monoinfect
coinfect
group
chisquar
test
independ
proport
use
analyz
clinic
sever
mono
coinfect
patient
twotail
p
valu
consid
signific
total
influenza
posit
sampl
neg
sampl
screen
presenc
common
respiratori
virus
influenza
sampl
origin
adult
age
children
age
median
age
yr
thirti
influenza
sampl
screen
posit
presenc
viral
copathogen
includ
rhinoviru
coronavirus
adenoviru
human
parainfluenza
type
wu
polyomaviru
rsv
tabl
one
pediatr
patient
identifi
coinfect
coronaviru
addit
influenza
neither
hmpv
hcov
detect
except
rsv
proport
patient
posit
test
virus
similar
patient
without
influenza
infect
median
age
coinfect
individu
yr
includ
adult
median
age
yr
children
median
age
yr
adult
rhinoviru
coinfect
children
vs
respect
chart
monoinfect
coinfect
patient
avail
chart
review
clinic
sever
calcul
median
clinic
sever
monoinfect
coinfect
group
tabl
howev
influenza
patient
coinfect
rhinoviru
tend
lower
clinic
sever
median
wherea
non
rhinoviru
coinfect
substanti
higher
clinic
sever
median
group
coinfect
individu
higher
proport
sever
diseas
css
compar
influenza
monoinect
vs
p
major
deriv
nonrhinoviru
coinfect
coinfect
adult
children
sever
diseas
similar
rate
vs
major
influenza
monoinfect
patient
sever
diseas
adult
compar
children
influenza
patient
rhinoviru
coinfect
tend
less
admiss
hospit
vs
oxygen
use
vs
tabl
nonrhinoviru
coinfect
significantli
higher
ventil
use
vs
sever
hypoxia
vs
compar
influenza
monoinfect
patient
p
coronaviru
coinfect
surprisingli
high
css
median
admit
hospit
requir
oxygen
use
well
requir
mechan
ventil
influenza
viral
load
calcul
quantit
rtpcr
figur
signific
differ
mean
viral
load
observ
coinfect
monoinfect
group
influenza
titer
origin
sampl
coinfect
rhinoviru
similar
influenza
sampl
coinfect
virus
sever
report
viral
interact
measur
outcom
cours
infect
howev
interact
rel
unexplor
given
number
viral
ill
occur
investig
focu
lifelong
viral
infect
hiv
epsteinbarr
hepat
c
due
rel
short
durat
viral
respiratori
infect
coinfect
thought
less
concern
begin
recogn
divers
nasopharyng
microbiom
normal
diseas
state
come
realiz
codetect
pathogen
may
becom
norm
make
understand
clinic
relev
pathogen
pair
essenti
one
first
investig
quantifi
clinic
sever
influenza
diseas
base
specif
copathogen
coinfect
rate
similar
report
studi
differ
patient
popul
time
sampl
collect
select
pathogen
screen
screen
methodolog
contribut
varianc
coinfect
rate
studi
howev
sensit
diagnost
method
becom
wide
use
combin
identif
previous
unrecogn
viral
pathogen
expect
number
influenza
codetect
increas
similar
investig
predomin
pathogen
coinfect
influenza
rhinoviru
rhinoviru
histor
consid
ubiquit
clinic
mild
yet
grow
number
report
challeng
notion
rhinoviru
coinfect
associ
wors
diseas
coinfect
rsv
find
demonstr
true
regard
influenza
rhinoviru
coinfect
littl
impact
influenza
diseas
fact
milder
find
sever
key
area
opposit
true
patient
coronavirusinfluenza
coinfect
compar
studi
observ
total
number
influenza
coronaviru
coinfect
low
find
result
diseas
substanti
sever
highlight
import
recogn
respiratori
viru
pair
distinct
clinic
entiti
viral
interfer
season
virus
especi
rhinoviru
pandem
influenza
suggest
recent
much
base
surveil
infer
relationship
rhinoviru
influenza
detect
howev
studi
demonstr
influenza
viral
titer
alter
viral
coinfect
suggest
obstruct
influenza
growth
either
directli
indirectli
occur
explan
diseas
sever
alter
without
chang
viral
titer
may
lie
result
immunolog
respons
investig
host
cytokin
cellular
respons
associ
coinfect
logic
next
step
recogn
absenc
specif
coinfect
may
import
observ
rsv
significantli
absent
influenza
sampl
greater
expect
coinfect
occur
chanc
alon
pattern
often
note
rsv
influenza
parainfluenza
one
epidem
respiratori
virus
reach
peak
other
seem
rel
inact
one
wonder
reason
behind
pattern
involv
direct
indirect
viral
interact
includ
chang
tissu
permiss
viral
replic
host
immunolog
respons
studi
sever
limit
first
possibl
viral
pathogen
target
coinfect
rate
may
even
higher
expand
number
pathogen
includ
enteroviru
influenza
viru
type
b
c
time
present
also
vari
within
group
may
affect
sensit
viral
detect
advanc
molecular
modal
includ
masstag
pcr
virochip
deep
sequenc
ultim
provid
complet
pictur
coinfect
frequenc
well
describ
sever
clinic
ill
pandem
associ
underli
comorbid
includ
obes
diabet
pregnanc
collect
screen
sampl
well
use
clinic
sever
score
independ
patient
underli
comorbid
addit
patient
comorbid
sever
ill
may
also
associ
factor
delay
medic
attent
lack
antivir
therapi
larger
studi
includ
multivari
analysi
paramet
undertaken
import
note
morbid
mortal
pandem
influenza
viru
differ
season
influenza
virus
therefor
clear
happen
pandem
influenza
viru
extrapol
season
influenza
virus
also
rel
humid
affect
influenza
viru
transmiss
influenza
viru
surviv
comparison
find
influenza
spread
mainli
contact
similar
rhinoviru
time
higher
absolut
humid
spread
small
particl
aerosol
peak
lower
humid
may
differ
may
explain
differ
find
compar
similar
studi
furthermor
point
diseas
sever
like
depend
type
coinfect
pathogen
number
certain
codetect
pathogen
infect
patient
small
detail
analysi
continu
investig
multipl
season
requir
answer
question
despit
limit
demonstr
clinic
relev
influenza
viral
coinfect
vari
greatli
may
associ
coinfect
pathogen
involv
recognit
respiratori
viral
coinfect
increas
advanc
sensit
multiplex
screen
respiratori
sampl
sensit
diagnost
method
increas
number
viral
coinfect
continu
rise
investig
quantifi
effect
viral
coinfect
identif
relev
copathogen
pair
paramount
understand
viral
pathogenesi
quantit
rtpcr
influenza
mono
coinfect
patient
boxplot
demonstr
lower
upper
quartil
light
dark
shade
respect
well
minimum
maximum
valu
bar
group
